ABOS — Acumen Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Acumen Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -101 | -42.9 | -52.4 | -102 | -121 |
| Depreciation | |||||
| Non-Cash Items | 82.3 | 3.69 | 5.38 | 4.4 | 10.9 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.298 | 3.99 | 3.87 | 11.7 | -5.12 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -18 | -35.2 | -43.1 | -86.2 | -116 |
| Capital Expenditures | -0.04 | -0.161 | -0.021 | -0.016 | -0.088 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -104 | 39.3 | -172 | 48 | 134 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -104 | 39.2 | -172 | 48 | 134 |
| Financing Cash Flow Items | — | — | -0.476 | -0.23 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 200 | 3.91 | 152 | 6.93 | -0.034 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 78.4 | 7.94 | -63 | -31.3 | 18.4 |